Literature DB >> 20601111

Direct evidence for leptin-induced lipid oxidation independent of long-form leptin receptor.

Yunike Akasaka1, Masaki Tsunoda, Tomomi Ogata, Tomohiro Ide, Koji Murakami.   

Abstract

Leptin administration has been shown to enhance muscle lipid oxidation in relation to the energy expenditure. Both long-form (Ob-R(L)) and short-form leptin receptors (Ob-R(S)) are expressed in skeletal muscle, but the role of Ob-R(S) is unclear. In the present study, the role of Ob-R(S) in leptin-induced lipid oxidation in skeletal muscles was investigated using primary murine myotubes from m/m and db/db mice. Primary myotubes were treated with leptin (0.1, 1, 10, 100nM) for 24h. Lipid oxidation was determined by (14)CO(2) production rate from [1-(14)C] palmitate. Leptin was found to increase lipid oxidation in a dose- and time-dependent manner in db/db myotubes as well as in m/m myotubes. Leptin significantly increased phosphorylation of JAK2 and STAT3 in both types of myotube. Leptin-induced lipid oxidation was abolished by STAT3 siRNA. To investigate the mechanism underlying leptin-induced lipid oxidation, the effects of pharmacological inhibitors were examined. JAK2 or p38 MAPK inhibitor suppressed leptin-induced lipid oxidation and decreased STAT3 phosphorylation in both types of myotube, respectively. Leptin significantly increased phosphorylation of p38 MAPK, and leptin-induced lipid oxidation was abolished by treatment with p38 MAPK siRNA in both types of myotube. These results suggest that leptin induces lipid oxidation in skeletal muscle through the JAK2/p38 MAPK/STAT3 signaling pathway via not only Ob-R(L) but also Ob-R(S). Copyright @ 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601111     DOI: 10.1016/j.bbalip.2010.06.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Endothelial leptin receptor mutation provides partial resistance to diet-induced obesity.

Authors:  Weihong Pan; Hung Hsuchou; Germaine G Cornelissen-Guillaume; Bhavvani Jayaram; Yuping Wang; Hong Tu; Franz Halberg; Xiaojun Wu; Streamson C Chua; Abba J Kastin
Journal:  J Appl Physiol (1985)       Date:  2012-02-09

Review 2.  Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism.

Authors:  Sandra Pereira; Daemon L Cline; Maria M Glavas; Scott D Covey; Timothy J Kieffer
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

3.  Novel regulatory mechanisms for generation of the soluble leptin receptor: implications for leptin action.

Authors:  Michael Schaab; Henriette Kausch; Juergen Klammt; Marcin Nowicki; Ulf Anderegg; Rolf Gebhardt; Stefan Rose-John; Juergen Scheller; Joachim Thiery; Juergen Kratzsch
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

4.  A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn's disease.

Authors:  H O Al-Hassi; D Bernardo; A U Murugananthan; E R Mann; N R English; A Jones; M A Kamm; N Arebi; A L Hart; A I F Blakemore; A J Stagg; S C Knight
Journal:  Mucosal Immunol       Date:  2012-11-21       Impact factor: 7.313

5.  Dichotomous roles of leptin and adiponectin as enforcers against lipotoxicity during feast and famine.

Authors:  Roger H Unger; Philipp E Scherer; William L Holland
Journal:  Mol Biol Cell       Date:  2013-10       Impact factor: 4.138

6.  Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.

Authors:  Tomohiko Ohno; Masahito Shimizu; Yohei Shirakami; Atsushi Baba; Takahiro Kochi; Masaya Kubota; Hisashi Tsurumi; Takuji Tanaka; Hisataka Moriwaki
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

7.  Serum Adiponectin and Leptin Concentrations in Relation to Body Fat Distribution, Hematological Indices and Lipid Profile in Humans.

Authors:  Anna Lubkowska; Aleksandra Radecka; Iwona Bryczkowska; Iwona Rotter; Maria Laszczyńska; Wioleta Dudzińska
Journal:  Int J Environ Res Public Health       Date:  2015-09-14       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.